These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1637881)

  • 41. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
    Buhr T; Georgii A; Choritz H
    Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histopathology of bone marrow in human chronic leukemias.
    Georgii A
    Haematol Blood Transfus; 1979; 23():59-70. PubMed ID: 296116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Thrombocytosis versus thrombocythemia--differential diagnosis of elevated platelet count].
    Thiele J; Kvasnicka HM
    Pathologe; 2000 Jan; 21(1):31-8. PubMed ID: 10663667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
    [No Abstract]   [Full Text] [Related]  

  • 45. Classification of myeloproliferative disorders by bone marrow histology.
    Frisch B; Bartl R; Burkhardt R; Jäger K; Mahl G; Kettner G
    Bibl Haematol; 1984; (50):57-80. PubMed ID: 6590039
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.
    Ludwig H; Linkesch W; Gisslinger H; Fritz E; Sinzinger H; Radaszkiewicz T; Chott A; Flener R; Micksche M
    Cancer Immunol Immunother; 1987; 25(3):266-73. PubMed ID: 3677127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis.
    Jacobsson S; Carneskog J; Ridell B; Wadenvik H; Swolin B; Kutti J
    Eur J Haematol; 1996 May; 56(5):287-92. PubMed ID: 8641402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R; Frisch B; Wilmanns W
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human megakaryocytes. III. Characterization in myeloproliferative disorders.
    Rabellino EM; Levene RB; Nachman RL; Leung LL
    Blood; 1984 Mar; 63(3):615-22. PubMed ID: 6230121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
    Thiele J; Kvasnicka HM; Schmitt-Gräff A
    Pathologe; 2002 Nov; 23(6):426-32. PubMed ID: 12436295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleolar organizer regions of megakaryocytes in chronic myeloproliferative disorders.
    Matolcsy A; Nádor R; Wéber E; Kónya T
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):441-5. PubMed ID: 1375798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia.
    Haznedaroğlu IC; Ertenli I; Ozcebe OI; Kiraz S; Ozdemir O; Sayinalp NM; Dündar SV; Calgüneri M; Kirazli S
    Acta Haematol; 1996; 95(2):107-11. PubMed ID: 8638438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
    Frisch B; Bartl R; Burkhardt R; Jäger K
    Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
    Georgii A; Buhr T; Buesche G; Kreft A; Choritz H
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():15-29. PubMed ID: 8951769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Megakaryocytes emperipolesis in bone marrow of the patients with non-Hodgkin's lymphoma.
    Dziecioł J; Lemancewicz D; Kłoczko J; Bogusłowicz W; Lebelt A
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():142-3. PubMed ID: 11820577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproducibility of histologic classification in nonfibrotic myeloproliferative neoplasia.
    Koopmans SM; Bot FJ; Lam KH; van Marion AM; de Raeve H; Hebeda KM
    Am J Clin Pathol; 2011 Oct; 136(4):618-24. PubMed ID: 21917685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The myeloproliferative disorders. An historical appraisal and personal experiences.
    Michiels JJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():1-14. PubMed ID: 8951768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.